E
Ehsan Chitsaz
Researcher at National Institutes of Health
Publications - 48
Citations - 742
Ehsan Chitsaz is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Tuberculosis & Regimen. The author has an hindex of 17, co-authored 42 publications receiving 664 citations. Previous affiliations of Ehsan Chitsaz include University of Tehran & Harbin Institute of Technology.
Papers
More filters
Journal ArticleDOI
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance
Masoud Shamaei,Majid Marjani,Ehsan Chitsaz,Mehdi Kazempour,Mehdi Esmaeili,Parisa Farnia,Payam Tabarsi,M. Amiri,Mehdi Mirsaeidi,Davood Mansouri,Mohammad R. Masjedi,Ali Akbar Velayati +11 more
TL;DR: There has been an increasing trend in drug resistance in recent years, particularly in retreatment cases, and revision of the national TB control program, reevaluation of the role of the World Health Organization category II (CAT II) regimen, as well as the conducting of a nationwide drug resistance survey are recommended.
Journal Article
Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006.
Mohammad Reza Masjedi,Payam Tabarsi,Ehsan Chitsaz,Parvaneh Baghaei,Mehdi Mirsaeidi,M. Amiri,Parissa Farnia,Pedram Javanmard,Davood Mansouri,Ali Akbar Velayati +9 more
TL;DR: Compared with previous studies, this study was able to obtain more favourable outcomes of MDR-TB treatment using a standardised regimen and ethambutol and pyrazinamide were added to the regimen.
Journal ArticleDOI
Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-infected Persons Entering Jail
Ehsan Chitsaz,Jaimie P. Meyer,Archana Krishnan,Sandra A. Springer,Ruthanne Marcus,Nick Zaller,Alison O. Jordan,Thomas M. Lincoln,Timothy P. Flanigan,Jeff Porterfield,Frederick L. Altice +10 more
TL;DR: Evidence-based drug treatments that include multi-faceted interventions, including medication-assisted therapies, are urgently needed to effectively engage this vulnerable population of people living with HIV/AIDS.
Journal ArticleDOI
Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases.
Parvaneh Baghaei,Payam Tabarsi,Ehsan Chitsaz,Masoumeh Saleh,Majid Marjani,Shahrzad Shemirani,Majid Valiollah Pooramiri,Mehdi Kazempour,Parisa Farnia,Fanak Fahimi,Davood Mansouri,Mohammad Reza Masjedi +11 more
TL;DR: It is indicated that DIH most often occurs during the first 2 weeks of anti-TB treatment, and development is associated with old age, certain clinical manifestations, and higher death rates.
Journal ArticleDOI
Post-Release Substance Abuse Outcomes Among HIV-Infected Jail Detainees: Results from a Multisite Study
Archana Krishnan,Jeffrey A. Wickersham,Ehsan Chitsaz,Sandra A. Springer,Alison O. Jordan,Nick Zaller,Frederick L. Altice +6 more
TL;DR: An approach that integrates multiple services, simultaneously using evidence-based substance abuse, psychiatric care, and social services is needed to improve healthcare outcomes for HIV-infected persons transitioning from jails to the community.